Home Bad Drugs Medical Devices Asbestos Blog Contact Us

Reglan Tardive Dyskinesia Neurological Disorder Lawsuits
(GERD and GER Drug Reaction Lawyer)

Tardive dyskinesia is a neurological disorder that exhibits itself through repetitive, involuntary, & purposeless movements like grimacing; tongue protrusion; lip smacking, puckering & pursing; and rapid eye blinking.  Victims of tardive dyskinesia also can exhibit rapid & involuntary movements of the arms and legs.  The neurological disorder can be caused by Reglan Tablets, Reglan Oral Disintegrating Tablets, Metoclopramide Oral Solution, and Reglan Injections. 

If your child, yourself, or someone else that you love has been given Reglan and has exhibited Tardive Dyskinesia symptoms, make sure that you get this person to a proper medical doctor, then feel free to e-mail your questions about Reglan and Tardive Dyskinesia.

FDA Requires Boxed Warning for Reglan and other Metoclopramide Containing Drugs (Tardive Dyskinesia GER and GERD Lawsuits)

On February 26, 2009, the U.S. Food and Drug Administration announced that manufacturers of metoclopramide, a drug used to treat gastrointestinal disorders, must add a boxed warning to their drug labels about the risk of its long-term or high-dose use. Chronic use of metoclopramide has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken.

Manufacturers are required to implement a risk evaluation and mitigation strategy, or REMS, to ensure patients are provided with a medication guide that discusses this risk.

The FDA wants patients and health care professionals to know about this risk so they can make informed decisions about treatment, said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research. The chronic use of metoclopramide therapy should be avoided in all but rare cases where the benefit is believed to outweigh the risk.

Current product labeling warns of the risk of tardive dyskinesia with chronic metoclopramide treatment. The development of this condition is directly related to the length of time a patient is taking metoclopramide and the number of doses taken. Those at greatest risk include the elderly, especially older women, and people who have been on the drug for a long time.

Tardive dyskinesia is characterized by involuntary, repetitive movements of the extremities, or lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers. These symptoms are rarely reversible and there is no known treatment. However, in some patients, symptoms may lessen or resolve after metoclopramide treatment is stopped.

Metoclopramide works by speeding up the movement of the stomach muscles, thus increasing the rate at which the stomach empties into the intestines. It is used as a short-term treatment of gastroesophageal reflux disease in patients who have not responded to other therapies, and to treat diabetic gastroparesis (slowed emptying of the stomach's contents into the intestines). It is recommended that treatment not exceed three months.

Metoclopramide is available in a variety of formulations including tablets, syrups and injections. Names of metoclopramide-containing products include Reglan Tablets, Reglan Oral Disintegrating Tablets, Metoclopramide Oral Solution, and Reglan Injection. More than two million Americans use these products.

Recently published analyses suggest that metoclopramide is the most common cause of drug-induced movement disorders. Another analysis of study data by the FDA showed that about 20 percent of patients in that study who used metoclopramide took it for longer than three months. The FDA has also become aware of continued spontaneous reports of tardive dyskinesia in patients who used metoclopramide, the majority of whom had taken the drug for more than three months.

Reglan Tardive Dyskinesia Lawsuits (GER and GERD Malpractice)

Gastroesophageal reflux disease (GERD) is a more serious form of gastroesophageal reflux (GER), which is common.   GER occurs when the lower esophageal sphincter (LES) opens spontaneously, for varying periods of time, or does not close properly and stomach contents rise up into the esophagus. GER is also called acid reflux or acid regurgitation, because digestive juicesócalled acidsórise up with the food.

When acid reflux occurs, food or fluid can be tasted in the back of the mouth. When refluxed stomach acid touches the lining of the esophagus it may cause a burning sensation in the chest or throat called heartburn or acid indigestion. Occasional GER is common and does not necessarily mean one has GERD. Persistent reflux that occurs more than twice a week is considered GERD, and it can eventually lead to more serious health problems. People of all ages can have GERD.

An estimated two-thirds of all infants suffer from GER, though the pathological condition called GERD (gastroesophageal reflux disease) affects approximately only one in 300 babies.

Reglan is a neuroleptic medication used to treat gastrointestinal problems that have had many cases of Tardive Dyskinesia reported in response to it. Reglan is supposed to increase the stomach and small intestine contractions to help the passage of food. As every medication, Reglan has side effects associated to it and some of them are very serious. In February 1996, the FDA warned that Reglan causes an increased risk of Parkinsonism.

Reglan is a dopamine antagonist that increases lower esophageal sphincter pressure and improves gastrointestinal emptying. The FDA approved Reglan, which is manufactured by Baxter Healthcare Corporation, for short-term treatment (between 4 and 12 weeks) of these conditions only after conservative methods of treatment have failed. However, it is common that patients are prescribed Reglan for longer than 12 weeks, which is against FDA recommendations.

 

This is problematic because prolonged use of Reglan can cause Tardive Dyskinesia, a serious and often irreversible movement disorder. Infants who are given Reglan appear to be at an even greater risk for this serious drug side effect.

The symptoms a person can experience from Tardive Dyskinesia can vary from mild barely noticeable facial ticks and involuntary movements to severe problems. Severe cases of Tardive Dyskinesia can have a significant impact on a person's life disabling them from normal functioning.  Severe facial ticks and involuntary body movements can be extremely embarrassing cause a person to withdraw from social interactions.

Texas Tardive Dyskinesia (Drug Reactions)

If you have any questions about Tardive Dyskinesia that you think was caused by Reglan any other Metoclopramide Containing Drugs, please feel free to e-mail your questions.

The ToxicDoseLaw.com Website was developed by Texas Dangerous Drug Attorney Jason Coomer. He is a Texas Reglan Lawyer who commonly works with other Reglan Tardive Dyskinesia Lawyers including Houston Tardive Dyskinesia lawyers, Dallas GERD Medical Malpractice Lawyers, San Antonio GERD Malpractice Lawyers, and other Austin Reglan Medical Negligence Lawyers on a variety of product liability and medical malpractice lawsuits.  By sharing information and working together, his law firm and other firms throughout the nation are able to provide better representation for there clients.  For more information on Texas Lawyer Jason Coomer, go to his Law Firm's Web Site.


     The ToxicDoseLaw.com website provides information on dangerous medications, bad drugs, dangerous products, toxic substances, and defective products that can cause serious toxic exposures, toxic deaths, serious diseases including mesothelioma & cancer, or toxic exposures.

       It is well established that many large corporations have profited from selling toxic products or products that cause toxic exposure without regard to the health consequences of the products.  Some of the most well known toxic products are asbestos products and bad drugs.  The asbestos products have been found to cause mesothelioma and several forms of cancer and other asbestos diseases, while dangerous drugs have been linked to death, serious heart problems, drug interactions, and suicide.  Other dangerous products that have been linked to serious disease include silica, chemical pollutants, lead, radon, EMFs, welding rodstoxic mold infestations and other environmental toxins have caused death and serious harm to millions.  In the work environment alone undisclosed and known toxins including asbestos, silica, and welding rods have caused occupational diseases and fatalities including mesothelioma, numerous forms of cancer, and Parkinson's disease.

     This web site was created by Texas Toxic Tort Lawyer Jason Coomer and is intended only as general information on some of the most dangerous products and toxic products that have been sold by drug manufacturers, medical device manufacturers, and asbestos manufacturers, or are in use by large companies attempting to profit and make money from the sale of dangerous products that can cause serious toxic exposures.  For more information on a dangerous product or toxic exposure follow the links found above, e-mail  an inquiry to info@toxicdoselaw.com, or submit an inquiry.

     This website provides basic information on some well established toxins and some potential toxins that are best to avoid.  Overall, ToxicDoseLaw.com and ToxicExposureLaw.com recommend using the precautionary principle by minimizing exposure to potential toxins until they can be proven nontoxic.

     For more information on the ToxicDoseLaw.com or ToxicExposureLaw.com information center, follow the links on this website, submit an inquiry, email us at info@toxicdoselaw.com or call us at (512) 474-5577.


Submit an Inquiry


* Name (Required):
* Email (Required):
Phone Number:
* Your Message (Required):
Anti-spam Question:
*Using only numbers,
what is 2 plus 2?

 
| Home | Bad Drugs | Medical Devices | Asbestos  | Blog | Contact |

Jurisdiction for the ToxicDoseLaw.com and ToxicExposureLaw.com Web Presence is in Austin, Travis County, Texas.
AbogadosdeTejas.com, LLC, Copyright © 1999-2012